Robertson, R. C., Manges, A. R., Finlay, B. B. & Prendergast, A. J. The human microbiome and child growth — first 1000 days and beyond. Trends Microbiol. 27, 131–147 (2019).
Fuchs, C. D. & Trauner, M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat. Rev. Gastroenterol. Hepatol. 19, 432–450 (2022).
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J. & Schoonjans, K. Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 7, 678–693 (2008).
Wahlstrom, A., Sayin, S. I., Marschall, H. U. & Backhed, F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24, 41–50 (2016).
Belkaid, Y. & Hand, T. W. Role of the microbiota in immunity and inflammation. Cell 157, 121–141 (2014).
Blander, J. M., Longman, R. S., Iliev, I. D., Sonnenberg, G. F. & Artis, D. Regulation of inflammation by microbiota interactions with the host. Nat. Immunol. 18, 851–860 (2017).
Hang, S. Y. et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature 576, 143–148 (2019).
Morais, L. H., Schreiber, H. L. T. & Mazmanian, S. K. The gut microbiota–brain axis in behaviour and brain disorders. Nat. Rev. Microbiol. https://doi.org/10.1038/s41579-020-00460-0 (2020).
Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55–71 (2021).
Nicholson, J. K. et al. Host–gut microbiota metabolic interactions. Science 336, 1262–1267 (2012).
Martin, A. M., Sun, E. W., Rogers, G. B. & Keating, D. J. The influence of the gut microbiome on host metabolism through the regulation of gut hormone release. Front. Physiol. 10, 428 (2019).
Molinaro, A., Wahlstrom, A. & Marschall, H. U. Role of bile acids in metabolic control. Trends Endocrinol. Metab. 29, 31–41 (2018).
Ramírez-Pérez, O., Cruz-Ramón, V., Chinchilla-López, P. & Méndez-Sánchez, N. The role of the gut microbiota in bile acid metabolism. Ann. Hepatol. 16, s15–s20 (2017).
Wang, H., Chen, J., Hollister, K., Sowers, L. C. & Forman, B. M. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 3, 543–553 (1999).
Claudel, T., Staels, B. & Kuipers, F. The farnesoid X receptor — a molecular link between bile acid and lipid and glucose metabolism. Arterioscler. Thromb. Vasc. Biol. 25, 2020–2031 (2005).
Jiang, L., Zhang, H., Xiao, D., Wei, H. & Chen, Y. Farnesoid X receptor (FXR): structures and ligands. Comput. Struct. Biotechnol. J. 19, 2148–2159 (2021).
Johnson, M. R., Barnes, S., Kwakye, J. B. & Diasio, R. B. Purification and characterization of bile acid-CoA:amino acid N-acyltransferase from human liver. J. Biol. Chem. 266, 10227–10233 (1991).
Killenberg, P. G. & Jordan, J. T. Purification and characterization of bile acid-CoA:amino acid N-acyltransferase from rat liver. J. Biol. Chem. 253, 1005–1010 (1978).
Funabashi, M. et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature 582, 566–570 (2020).
White, B. A., Lipsky, R. L., Fricke, R. J. & Hylemon, P. B. Bile acid induction specificity of 7α-dehydroxylase activity in an intestinal Eubacterium species. Steroids 35, 103–109 (1980).
Jones, B. V., Begley, M., Hill, C., Gahan, C. G. & Marchesi, J. R. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc. Natl Acad. Sci. USA 105, 13580–13585 (2008).
Ridlon, J. M., Harris, S. C., Bhowmik, S., Kang, D. J. & Hylemon, P. B. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 7, 22–39 (2016).
Pandak, W. M. & Kakiyama, G. The acidic pathway of bile acid synthesis: not just an alternative pathway. Liver Res. 3, 88–98 (2019).
Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-β-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225–235 (2013).
Sun, L. et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat. Med. 24, 1919–1929 (2018).
Makishima, M. et al. Identification of a nuclear receptor for bile acids. Science 284, 1362–1365 (1999).
Reschly, E. J. et al. Evolution of the bile salt nuclear receptor FXR in vertebrates. J. Lipid Res. 49, 1577–1587 (2008).
Chiang, J. Y. Bile acids: regulation of synthesis. J. Lipid Res. 50, 1955–1966 (2009).
Brandman, O. & Meyer, T. Feedback loops shape cellular signals in space and time. Science 322, 390–395 (2008).
Tautenhahn, R., Patti, G. J., Rinehart, D. & Siuzdak, G. XCMS Online: a web-based platform to process untargeted metabolomic data. Anal. Chem. 84, 5035–5039 (2012).
Helf, M. J., Fox, B. W., Artyukhin, A. B., Zhang, Y. K. & Schroeder, F. C. Comparative metabolomics with Metaboseek reveals functions of a conserved fat metabolism pathway in C. elegans. Nat. Commun. 13, 782 (2022).
Arifuzzaman, M. et al. Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation. Nature https://doi.org/10.1038/s41586-022-05380-y (2022).
Singh, V. et al. Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer. Cell 175, 679–694.e22 (2018).
Naquet, P., Kerr, E. W., Vickers, S. D. & Leonardi, R. Regulation of coenzyme A levels by degradation: the ‘ins and outs’. Prog. Lipid Res. 78, 101028 (2020).
Hunt, M. C., Siponen, M. I. & Alexson, S. E. The emerging role of acyl-CoA thioesterases and acyltransferases in regulating peroxisomal lipid metabolism. Biochim. Biophys. Acta 1822, 1397–1410 (2012).
Neugebauer, K. A. et al. BAAT gene knockout alters early life development and the gut microbiome and reveals unusual bile acids in mice. J. Lipid Res. 63, 100297 (2022).
Bartucci, R., Salvati, A., Olinga, P. & Boersma, Y. L. Vanin 1: its physiological function and role in diseases. Int. J. Mol. Sci. 20, 3891 (2019).
Kaskow, B. J., Proffitt, J. M., Blangero, J., Moses, E. K. & Abraham, L. J. Diverse biological activities of the vascular non-inflammatory molecules — the vanin pantetheinases. Biochem. Biophys. Res. Commun. 417, 653–658 (2012).
Yu, H. et al. Vanin1 (VNN1) in chronic diseases: future directions for targeted therapy. Eur. J. Pharmacol. 962, 176220 (2024).
Yao, L. et al. A selective gut bacterial bile salt hydrolase alters host metabolism. eLife https://doi.org/10.7554/eLife.37182 (2018).
Al-Dury, S., Wahlstrom, A., Stahlman, M., Backhed, F. & Marschall, H. U. Cyp3a11 is dispensable for the formation of murine bile acids. J. Hepatol. 64, S436 (2016).
Guzior, D. V. et al. Bile salt hydrolase acyltransferase activity expands bile acid diversity. Nature https://doi.org/10.1038/s41586-024-07017-8 (2024).
Quinn, R. A. et al. Global chemical effects of the microbiome include new bile-acid conjugations. Nature 579, 123–129 (2020).
Voegel, J. J., Heine, M. J., Zechel, C., Chambon, P. & Gronemeyer, H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15, 3667–3675 (1996).
Willson, T. M., Jones, S. A., Moore, J. T. & Kliewer, S. A. Chemical genomics: functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism. Med. Res. Rev. 21, 513–522 (2001).
Jiang, C. et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat. Commun. 6, 10166 (2015).
Inagaki, T. et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217–225 (2005).
Kim, I. et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J. Lipid Res. 48, 2664–2672 (2007).
Gonzalez, F. J., Jiang, C., Xie, C. & Patterson, A. D. Intestinal farnesoid X receptor signaling modulates metabolic disease. Dig. Dis. 35, 178–184 (2017).
Cheng, K. et al. Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice. Oncotarget 9, 25572–25585 (2018).
Ito, S. et al. Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho. J. Clin. Invest. 115, 2202–2208 (2005).
Kuang, J. L. et al. Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut–liver axis. Cell Metab. 35, 1752–1766.e8 (2023).
Song, X. Y. et al. Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis. Nature 577, 410–415 (2020).
Campbell, C. et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature 581, 475–479 (2020).
Einarsson, C., Hillebrant, C. G. & Axelson, M. Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects. Hepatology 33, 1189–1193 (2001).
Li, C. et al. Farnesoid X receptor agonists as therapeutic target for cardiometabolic diseases. Front. Pharmacol. 11, 1247 (2020).
Ali, A. H., Carey, E. J. & Lindor, K. D. Recent advances in the development of farnesoid X receptor agonists. Ann. Transl. Med. 3, 5 (2015).
Ferrell, J. M. & Chiang, J. Y. L. Understanding bile acid signaling in diabetes: from pathophysiology to therapeutic targets. Diabetes Metab. J. 43, 257–272 (2019).
Li, T. & Apte, U. Bile acid metabolism and signaling in cholestasis, inflammation, and cancer. Adv. Pharmacol. 74, 263–302 (2015).
Mahanti, P. et al. Comparative metabolomics reveals endogenous ligands of DAF-12, a nuclear hormone receptor, regulating C. elegans development and lifespan. Cell Metab. 19, 73–83 (2014).
Pitari, G. et al. Pantetheinase activity of membrane-bound vanin-1: lack of free cysteamine in tissues of vanin-1 deficient mice. FEBS Lett. 483, 149–154 (2000).
Hepworth, M. R. et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells. Science 348, 1031–1035 (2015).
Letourneau, J. et al. Ecological memory of prior nutrient exposure in the human gut microbiome. ISME J. 16, 2479–2490 (2022).
Goc, J. et al. Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell 184, 5015–5030.e16 (2021).
Tautenhahn, R., Bottcher, C. & Neumann, S. Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics 9, 504 (2008).
Wang, M. et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 34, 828–837 (2016).
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
Zhang, B. et al. Acylspermidines are conserved mitochondrial sirtuin-dependent metabolites. Nat. Chem. Biol. 20, 812–822 (2024).
Parkhurst, C. Fiji oil red O macro. Zenodo https://doi.org/10.5281/zenodo.14031611 (2024).
